View : 16 Download: 0

Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System A Korean Gynecologic-Oncology Group Study

Title
Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System A Korean Gynecologic-Oncology Group Study
Authors
Kim, Mi KyoungSeong, Seok JuKim, Jae-WeonJeon, SeobChoi, Ho SunLee, In-HoLee, Jong HakJu, WoongSong, Eun SeopPark, HyunRyu, Hee-SugLee, ChulminKang, Soon-Beom
Ewha Authors
주웅
SCOPUS Author ID
주웅scopus
Issue Date
2016
Journal Title
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
ISSN
1048-891XJCR Link1525-1438JCR Link
Citation
vol. 26, no. 4, pp. 711 - 715
Keywords
Endometrial hyperplasiaProgesteroneLNG-IUSDilatation and curettageEndometrial aspiration biopsy
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
Objective: The aim of the study was to evaluate the efficacy of the levonorgestrel intrauterine system (LNG-IUS) for treatment of endometrial hyperplasia (EH). Methods: A prospective multicenter study was conducted from November 2010 to March 2014. Patients with histologically confirmed EH were treated with LNG-IUS. At 3, 6, and 9 months after LNG-IUS insertion, follow-up endometrial aspiration biopsies with the LNG-IUS in the uterus were undertaken. At the 12th month of follow-up, endometrial tissues were obtained via 2 methods: endometrial aspiration biopsy with the LNG-IUS in the uterus, followed by dilatation and curettage (D&C) after LNG-IUS removal. The primary outcome was the regression rate at 12 months after LNG-IUS insertion, and the secondary outcome was the consistency of the results between the endometrial aspiration biopsy and the D&C. Results: The study population comprised 75 patients, including 37 with simple hyperplasia without atypia; 3 with atypical simple hyperplasia; 23 with complex hyperplasia without atypia, and 12 with atypical complex hyperplasia. Of these patients treated with the LNGIUS, 38 (50.7%) were followed up at 12 months after LNG-IUS insertion. The complete regression rate at 12 months was 94.7% (36/38): 100% (6/6) of patients with atypical EH and 93.7% (30/32) with EH without atypia. In all of the cases (100%, 36/36), patients achieved complete regression within 3 months of LNG-IUS insertion. A comparison of the pathologic results from endometrial aspiration biopsy and D&C was carried out for 15 patients. In the histologic results by endometrial aspiration biopsy, 14 patients were diagnosed as "normal endometrium" and 1 as "insufficient tissue for pathologic evaluation." Among the 14 cases of normal endometrium by endometrial aspiration biopsy, 1 was diagnosed as "residual EH" by D&C, and the 1 case with insufficient tissue was diagnosed as normal endometrium by D&C. Conclusions: Levonorgestrel intrauterine system is an effective and favorable method for treatment of EH.
DOI
10.1097/IGC.0000000000000669
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE